Gefitinib: A Review of its Use in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.16, 2009-11, pp. : 2303-2328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Crizotinib: In Locally Advanced or Metastatic Non-Small Cell Lung Cancer

By Curran Monique P.

Drugs, Vol. 72, Iss. 1, 2012-01 ,pp. : 99-107

Adis International

Access to resources Recommend Favorite

Gefitinib: A Review of its Use in the Management of Advanced Non-Small-Cell Lung Cancer

By James E. Frampton Stephanie E. Easthope

Drugs, Vol. 64, Iss. 21, 2004-01 ,pp. : 2475-2492

Adis International

Access to resources Recommend Favorite

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer

By Vansteenkiste Johan Canon Jean-Luc Riska Henrik Pirker Robert Peterson Patrick John William Mali Pekka Lahn Michael

Investigational New Drugs, Vol. 23, Iss. 3, 2005-06 ,pp. : 263-269

Springer Publishing Company

Access to resources Recommend Favorite

Pemetrexed: A Review of its Use in the Management of Advanced Non-Squamous Non-Small Cell Lung Cancer

By Baldwin Claudine M. Perry Caroline M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2279-2302

Adis International

Access to resources Recommend Favorite

Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer

By Lyseng-Williamson Katherine A.

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 75-92

Adis International

Access to resources Recommend Favorite